Cargando…

Antivirals/glucocorticoids: Diabetes mellitus and ALT elevation following off-label use in COVID-19: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661815/ http://dx.doi.org/10.1007/s40278-020-86012-2

Ejemplares similares

Tocilizumab: Elevated AST and ALT following off label therapy: 11 case reports
Publicado: (2021)

Remdesivir: Elevated AST and ALT levels following off-label therapy: 4 case reports
Publicado: (2020)

Remdesivir: Elevated ALT level and lack of efficacy following off-label use: 13 case reports
Publicado: (2021)

Convalescent-anti-sars-cov-2-plasma/remdesivir: Sinus bradycardia, elevated ALT and off-label use: case report
Publicado: (2021)

Antivirals/interferon-α-1b: Elevated aminotransferases and vomiting following off-label use: case report
Publicado: (2021)

Dexamethasone: Glucocorticoid-induced hyperglycaemia following off label use : case report
Publicado: (2022)

Antivirals/immunosuppressants: COVID-19 infection and off label use: case report
Publicado: (2020)

Antivirals: Repolarisation and conduction disorder following off-label use: 2 case reports
Publicado: (2021)

Hydroxychloroquine: Elevated aminotransferase levels following off-label use: case report
Publicado: (2021)

Glucocorticoids/siltuximab/tocilizumab: Hepatitis-B reactivation following off-label use: 2 case reports
Publicado: (2021)

Antivirals/fluoroquinolones: Prolongation of QTc interval following off-label use: 9 case reports
Publicado: (2021)

Ribavirin: Mild elevation of bilirubin and AST/ALT: case report
Publicado: (2016)

Antibacterials/antivirals/immunosuppressants: COVID-19 infection, COVID-19 pneumonia and off-label use: 7 case reports
Publicado: (2022)

Azithromycin/hydroxychloroquine: Elevated liver enzymes following off label use: case report
Publicado: (2020)

Baricitinib/methylprednisolone/prednisolone: Elevated HBV DNA following an off label use: case report
Publicado: (2022)

Baricitinib/dexamethasone: Myalgia and elevated creatine kinase following an off-label use: case report
Publicado: (2022)

Antibacterials/antivirals: Off-label use in COVID-19 pneumonia, and induction of resistance through mutation selection: case report
Publicado: (2021)

Antibacterials/antivirals: QTc-interval prolongation and cardiac arrest following off-label therapy: 3 case reports
Publicado: (2021)

Antibacterials/antivirals: Erythema multiforme and off label use: 2 case reports
Publicado: (2020)

The role of elevated alanine aminotransferase (ALT), FasL and atherogenic dyslipidemia in type II diabetes mellitus
por: Mahran, Howayda N., et al.
Publicado: (2016)

Remdesivir: Acute kidney injury and elevated ALT level: 2 case reports
Publicado: (2022)

Favipiravir: Fever and elevated uric acid level following off-label therapy: 2 case reports
Publicado: (2021)

Multiple drugs: Elevated INR and off-label use: case report
Publicado: (2022)

Sevoflurane: Nephrogenic diabetes insipidus following off-label use: case report
Publicado: (2022)

Hydroxychloroquine: Myopathy with elevated creatine kinase and creatine kinase-MB following off-label use: case report
Publicado: (2021)

Multiple drugs: Mucormycosis following off-label use, elevated serum creatinine and hypokalaemia: 6 case reports
Publicado: (2022)

Multiple drugs: Elevated alanine transaminase and off label use: case report
Publicado: (2020)

Baricitinib/lopinavir/ritonavir: Elevated transaminases and off-label use: case report
Publicado: (2020)

Azithromycin: Elevated transaminase levels during off-label treatment: case report
Publicado: (2021)

Can elevated concentrations of ALT and AST predict the risk of ‘recurrence’ of COVID-19?
por: Chen, L. Z., et al.
Publicado: (2020)

Lopinavir/ritonavir: Acute hepatocellular hepatitis following off-label use in COVID-19: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Ventricular arrhythmias following off-label use in COVID-19: 2 case reports
Publicado: (2020)

Lopinavir/ritonavir: Various toxicities following off-label use in COVID-19: 4 case reports
Publicado: (2021)

Multiple drugs: COVID-19, and treatment failure following off-label use: 2 case reports
Publicado: (2021)

Hydroxychloroquine: Hepatotoxicity following off-label treatment: case report
Publicado: (2020)

Hydroxychloroquine: Rash following off label use: case report
Publicado: (2020)

Hydroxychloroquine: Haemolysis following off-label use: case report
Publicado: (2021)

Methylprednisolone: Bacteraemia following off label use: case report
Publicado: (2021)

Ceftriaxone: Cholelithiasis following off-label use: case report
Publicado: (2021)

Hydroxychloroquine: Eosinophilia following off-label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q8anl25377r2p6g9q19valukje